See All Slides - tctmd.com

Slides

Presentation TCT 2015

Stentys Self-Expanding Stent With a Durable Polymer Eluting Sirolimus: Extended 2-Year Clinical and OCT Results From APPOSITION IV

Presenter: Fernando Alfonso, Juan F. Granada, Robert-Jan van Geuns

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Simple and Complex CAD: Case Presentation

Presenter: Robert O. Bonow, Allan Schwartz, Jean-Michel Paradis

October 12, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation TCT 2015

Problem (and Solution) 4: Hematoma Management How to Avoid and How to Resolve the Difficult Antegrade Case

Presenter: Javier Escaned, William L. Lombardi, Elliot J. Smith

October 12, 2015

Presentation TCT 2015

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Presenter: John A. Bittl, Robert A. Harrington, David Erlinge

October 12, 2015

Presentation TCT 2015

Preoperative Planning for Mitral Valve-in-Valve/Ring Procedures: Integrating Imaging and the Mitral App

Presenter: Michael J. Mack, Francesco Maisano, Vinayak Bapat

October 12, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Gregg W. Stone

October 12, 2015

Presentation TCT 2015

A New Durable-PolymerBased Cobalt Chromium Stent: Rationale for and Design Characteristics of the BioNIR Stent and Clinical Development Program

Presenter: Fernando Alfonso, Juan F. Granada, Pieter C. Smits

October 12, 2015

Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Presenter: Ioanna Kosmidou, Bernard R. Chevalier

October 12, 2015

Advertisement

Slides

Stentys Self-Expanding Stent With a Durable Polymer Eluting Sirolimus: Extended 2-Year Clinical and OCT Results From APPOSITION IV

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Aortic Stenosis With Simple and Complex CAD: Case Presentation

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Problem (and Solution) 4: Hematoma Management How to Avoid and How to Resolve the Difficult Antegrade Case

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Preoperative Planning for Mitral Valve-in-Valve/Ring Procedures: Integrating Imaging and the Mitral App

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

A New Durable-PolymerBased Cobalt Chromium Stent: Rationale for and Design Characteristics of the BioNIR Stent and Clinical Development Program

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content